NCT04459650Early phase 1Completed
A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer
A Pilot Study of the Clinical Effectiveness of Platelet-Rich Plasma (PRP) for the Treatment of Endocrine Therapy-Induced Alopecia (EIA) and Permanent Chemotherapy-Induced Alopecia (pCIA) in Breast Cancer Patients
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Early phase 1
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Participants (registry)
- 30
- Start
- June 2020
- Primary completion
- August 2025
- Study completion
- August 2025
- Last registry update
- August 2025
- Countries
- United States
Conditions studied: Alopecia
Interventions: Platelet Rich Plasma system, PRP
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.